...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Strain-Specific Neutralizing Antibody Responses against Human Cytomegalovirus Envelope Glycoprotein N
【24h】

Strain-Specific Neutralizing Antibody Responses against Human Cytomegalovirus Envelope Glycoprotein N

机译:针对人巨细胞病毒包膜糖蛋白N的菌株特异性中和抗体反应

获取原文

摘要

The human cytomegalovirus (HCMV) gM-gN complex is a major target of virus-neutralizing activity, and gN subtypes induce strain-specific antibodies. However, the biological significance of HCMV gN polymorphisms is not known. Neutralizing antibody responses against HCMV gN recombinant viruses were investigated at study entry in 80 healthy HCMV-seropositive women who were monitored for the appearance of new antibody specificities against linear strain-specific epitopes on glycoproteins gH and gB as evidence of HCMV reinfection. Neutralizing activity against all four gN recombinant viruses was seen in 74% of subjects, and 61% of subjects had strain-specific responses. Significantly fewer women (9/39 subjects [23%]) with serological evidence of reinfection had strain-specific neutralizing responses than the women without reinfection (21/41 subjects [51%]). Women with antibodies against at least one of the four linear gB and gH antigens at study entry had higher neutralizing titers against gN-1 (P = 0.006) and gN-2 (P = 0.007). Neutralizing titers of ≥400 against gN-3 (P = 0.043) and gN-4 (P = 0.049) at study entry were associated with longer times to serological evidence of reinfection. The findings demonstrate that HCMV gN elicits strain-specific neutralizing antibody responses and that broader anti-gN neutralizing activity may provide some protection from reinfection with a different virus strain.
机译:人类巨细胞病毒(HCMV)gM-gN复合物是病毒中和活​​性的主要目标,而gN亚型则诱导出菌株特异性抗体。但是,HCMV gN多态性的生物学意义尚不清楚。在80名健康的HCMV血清反应阳性的健康妇女中,研究入组时对HCMV gN重组病毒的中和抗体应答进行了研究,这些妇女被监测了针对糖蛋白gH和gB上线性菌株特异性表位的新抗体特异性的出现,作为HCMV再感染的证据。在74%的受试者中发现了针对所有四种gN重组病毒的中和活性,而61%的受试者具有菌株特异性反应。具有再感染血清学证据的女性(9/39受试者[23%])比没有再次感染的女性(21/41受试者[51%]),具有菌株特异性中和反应的人数要少得多。在研究开始时具有针对四种线性gB和gH抗原中至少一种的抗体的女性对gN-1( P = 0.006)和gN-2( P = 0.007)。进入研究时针对gN-3( P = 0.043)和gN-4( P = 0.049)的中和滴度≥400与更长的再次感染血清学证据相关。这些发现表明,HCMV gN引起了菌株特异性中和抗体反应,而更广泛的抗gN中和活性可以提供某种保护,使其免于被另一种病毒株再感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号